Our passive immunity patent portfolio concerns the local or topical administration of monoclonal or polyclonal antibody compositions in the prevention and treatment of infectious disease. More
The novel compounds can be introduced easily into microorganisms such as fungi, Acanthamoeba and free-living Protozoa, thus allowing their detection and identification by fluorescence microscopy. More